DGHO spring conference 2013: Drug tumor therapy in focus

05.02.2013 17:22

Under the motto “Medical Oncology: New Drugs – Hopes with Risks,” the German Society for Hematology and Medical Oncology (DGHO) invites you to this year’s spring conference in Berlin. Well-known national and international experts are expected to attend the health policy dialogue on March 7th and 8th. For the first time, the conference is being organized together with the Society for Pediatric Oncology and Hematology (GPOH). The congress takes place at the dbb forum berlin and is certified with a total of 7 points.

The focus of the DGHO spring conference this year is drug tumor therapy. Oncological progress occurs in small developmental steps and raises new questions, such as how the benefit of a therapy can be assessed at an early stage, which endpoints actually allow statements to be made about the benefit of a therapy depending on the stage of the disease, or how the supply of effective cytostatic drugs can be better ensured.

The meetings on Thursday, March 7th will deal with the new possibilities of targeted cancer therapy, the definition of patient-relevant endpoints and (mis)management in the healthcare system with regard to the outpatient and inpatient sector and the payers. For the English-language session “Benefit-Risk Assessment of New Drugs – Patient Related Outcome” from 1:00 p.m. to 2:30 p.m., Prof. David Cella from Northwestern University Feinberg in Chicago was able to give a lecture on “Health Related Quality of Life”. become. Cella has been intensively involved in measuring health-related quality of life in clinical studies and clinical practice for years.

The health policy meeting on Friday, March 8th from 2:15 p.m. to 4:30 p.m. is dedicated to the urgent problem of drug shortages in oncology. Alan Howard, Managing Director of the European Society for Medical Oncology, will join Prof. Mathias Freund (DGHO) and Prof. Angelika Eggert (GPOH) in discussing the worrying increase in supply bottlenecks for oncological active ingredients in the recent past and possible strategies to avoid them.

The events are supplemented by the satellite symposiums “Patient-relevant endpoints in breast cancer” and “Clinical relevance vs. patient relevance?! – A position assessment”.

Further information about the program can be found at: www.dgho-service.de/tagungen_seminare_weiterbildungen/dgho_fruhjahrstagung

Spring conference 2013

Every year, the DGHO spring meeting is dedicated to medical policy topics and overarching content focuses in the form of lectures and panel discussions. The conference is an important forum for exchange about the various activities of the specialist society in the form of working group meetings, study director meetings of DGHO and GPOH, advisory board meetings and meetings of ADHOK and BNHO. For the first time, the conference will be organized together with the GPOH. The DGHO spring conference was certified by the LÄK Berlin on March 7, 2013 with 5 points and on March 8, 2013 with 2 points. Participation is free of charge; registration is requested.

DGHO German Society for Hematology and Medical Oncology

The DGHO German Society for Hematology and Medical Oncology eV has existed for 75 years and today has more than 2,700 members who are active in the research and treatment of hematological and oncological diseases. The specialist society promotes high-quality care for patients with hematological and oncological diseases by developing training, further education and continuing education curricula, drawing up treatment guidelines and treatment recommendations, and holding specialist conferences and advanced training seminars.

You can find the press release and further information about the DGHO spring conference on the specialist society's website www.dgho.de recall.